Cargando…

The use of adaptive intensity-modulated radiotherapy in the treatment of small-cell carcinoma lung refractory to chemotherapy in a patient with preexisting interstitial lung disease

This is a case report of a 60-year-old diabetic, hypertensive male with a good performance status and a history of bilateral interstitial lung disease with a left upper lobe lung mass diagnosed to be a Stage IIB mixed small-cell/squamous cell carcinoma which was refractory to carboplatin- and etopos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tandon, Sarthak, Gairola, Munish, Pal, Manoj, Aggarwal, Archana, Sharma, Kanika, Karimi, Ahmad Masroor, Mandal, Avik, Goyal, Rajiv, Batra, Ullas, Kaur, Inderjit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760870/ https://www.ncbi.nlm.nih.gov/pubmed/29319036 http://dx.doi.org/10.4103/lungindia.lungindia_93_17

Ejemplares similares

Health-related quality of life assessment for head-and-neck cancer patients during and at 3 months after radiotherapy – A prospective, analytical questionnaire-based study
por: Karimi, Ahmad Masroor, et al.
Publicado: (2019)

Prognostic factors, failure patterns and survival analysis in patients with resectable oral squamous cell carcinoma of the tongue
por: Sharma, Kanika, et al.
Publicado: (2019)

Sinonasal teratocarcinosarcoma treated with surgery followed by volumetric modulated radiotherapy: a case report with review of literature
por: Tandon, Sarthak, et al.
Publicado: (2018)

Effect of contrast medium on treatment modalities planned with different photon beam energies: a planning study
por: Bhushan, Manindra, et al.
Publicado: (2021)

Efficacy and safety of nivolumab in non‐small cell lung cancer with preexisting interstitial lung disease
por: Kanai, Osamu, et al.
Publicado: (2018)

MORTALITY AND ITS PREDICTORS IN PATIENTS WITH COVID-19 WITH PREEXISTING INTERSTITIAL LUNG DISEASE
por: DUTT, N., et al.
Publicado: (2022)

Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor–Induced Interstitial Lung Disease Among Patients With Nonlung Cancers
por: Shimoji, Kiyofumi, et al.
Publicado: (2020)

Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease
por: Gallay, Laure, et al.
Publicado: (2021)

Clinical significance of microscopic polyangiitis with interstitial lung disease and bronchiectasis: probability of preexisting comorbidities
por: Zhang, Yun, et al.
Publicado: (2023)

Impact of Preexisting Interstitial Lung Disease on Acute, Extensive Radiation Pneumonitis: Retrospective Analysis of Patients with Lung Cancer
por: Ozawa, Yuichi, et al.
Publicado: (2015)

Pembrolizumab for Previously Untreated Patients with Advanced Non-small-cell Lung Cancer and Preexisting Interstitial Lung Disease
por: Fujita, Tetsuo, et al.
Publicado: (2020)

Transbronchial Lung Cryobiopsy in Diffuse Interstitial Lung Diseases . . . Bent but Not Broken
por: Agarwal, Ritesh, et al.
Publicado: (2019)

The impact of COVID-19 on patients with preexisting interstitial lung disease: High mortality in these high-risk patients
por: Udwadia, Zarir Farokh, et al.
Publicado: (2021)

Impact of COVID-19 Infection on Patients with Preexisting Interstitial Lung Disease: A Spanish Multicentre Study
por: Martínez-Besteiro, Elisa, et al.
Publicado: (2023)

Clinical outcome study of crizotinib in immunohistochemistry-proven echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene among Indian patients with adenocarcinoma lung
por: Batra, Ullas, et al.
Publicado: (2018)

Noninvasive determinants of pulmonary hypertension in interstitial lung disease
por: Joseph, Phillip, et al.
Publicado: (2023)

Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy
por: Li, Fangjuan, et al.
Publicado: (2018)

Response to letter to the editor “noninvasive determinants of pulmonary hypertension in interstitial lung disease”
por: Joseph, Phillip, et al.
Publicado: (2023)

Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients
por: Mehta, Anurag, et al.
Publicado: (2020)

Treatment Delay during Radiotherapy of Cancer Patients due to COVID-19 Pandemic
por: Mitra, Swarupa, et al.
Publicado: (2022)

Molecular Response Assessment with Immune Adaptive PERCIST in Lung Cancer Patients Treated with Nivolumab: Is It Better Than iRECIST?
por: Gupta, Manoj, et al.
Publicado: (2022)

A case of pulmonary pleomorphic carcinoma with preexisting interstitial pneumonia successfully treated with pembrolizumab
por: Sako, Masahiro, et al.
Publicado: (2021)

Vulvar carcinoma: dilemma, debates, and decisions
por: Mitra, Swarupa, et al.
Publicado: (2018)

Radial endobronchial ultrasound for the diagnosis of bronchoscopically invisible lesions: First case series from India
por: Hibare, Kedar Ravi, et al.
Publicado: (2017)

Impact of antigen identification on transplant free survival in interstitial lung disease
por: Kypreos, Margaret, et al.
Publicado: (2023)

Real-World Evidence of Safety and Efficacy of Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel in Patients with Advanced Non-Small-Cell Lung Cancer and Preexisting Interstitial Lung Disease: A Retrospective Study
por: Araya, Tomoyuki, et al.
Publicado: (2019)

The association of preexisting severe asthma with COVID-19 outcomes
por: Terry, Paul D., et al.
Publicado: (2023)

Lung transplantation for interstitial lung disease
por: Kapnadak, Siddhartha G., et al.
Publicado: (2021)

ROS1 rearrangement and response to crizotinib in Stage IV non-small cell lung cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2017)

A rare case of rituximab induced interstitial lung disease
por: Sahu, Kamal Kant, et al.
Publicado: (2016)

A Multidisciplinary Approach for Patients with Preexisting Lung Diseases and Immune Checkpoint Inhibitor Toxicities
por: Naidoo, Jarushka, et al.
Publicado: (2020)

Successful Treatment of EGFR-Mutant Synchronous SCLC and Lung Adenocarcinoma With Osimertinib
por: Batra, Ullas, et al.
Publicado: (2020)

Efficacy and toxicity profile of maintenance pemetrexed in patients with stage IV adenocarcinoma lung in Indian population
por: Pankaj, Goyal, et al.
Publicado: (2016)

Long COVID Mimicking Interstitial Lung Disease: A Case Series
por: GOEL, NITIN, et al.
Publicado: (2021)

Interstitial Lung Disease
Publicado: (1982)

Interstitial Lung Diseases
por: Mueller-Mang, Christina, et al.
Publicado: (2009)

Interstitial Lung Diseases
por: Mueller-Mang, Christina, et al.
Publicado: (2017)

Interstitial lung disease
por: Antoniou, Katerina M., et al.
Publicado: (2014)

CT-based lung motion differences in patients with usual interstitial pneumonia and nonspecific interstitial pneumonia
por: Choi, Jiwoong, et al.
Publicado: (2022)

Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
por: Zhou, Qian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_83pgp6heko7nq4ajisnalvfudn